Investigation of the clinical safety and efficacy of iguratimod in patients with rheumatoid arthritis
Not Applicable
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-jRCT1080222730
- Lead Sponsor
- Toyama Chemical Co., Ltd. (Current FUJIFILM Toyama Chemical Co., Ltd.)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 2000
Inclusion Criteria
Patients with rheumatoid arthritis
All patients who take iguratimod
Exclusion Criteria
Pregnant women or women suspected of being pregnant
Patients with a serious liver disorder
Patients with peptic ulcer
Patients with known hypersensitivity to iguratimod or any of its
excipients
Patients receiving treatment with warfarin
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method